Cor Vasa 2019, 61(5):459-463 | DOI: 10.33678/cor.2019.035

P-wave dispersion and atrial electromechanical delay in patients with inflammatory bowel disease

Habibe Kafesa, Burak Açarb, Lale Asarciklic, Esra Gucuka, Zeki Mesut Yalin Kilicd, Omac Tufekcioglu
a Department of Cardiology, Yuksek Ihtisas Education and Research Hospital, Ankara, Turkey
b Department of Cardiology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey
c Department of Cardiology, Siyami Ersek Cardiovascular and Thoracic Surgery Center, İstanbul, Turkey
d Department of Gastroenterology, Yuksek Ihtisas Education and Research Hospital, Ankara, Turkey

Background: Inflammatory bowel disease (IBD) is a group of inflammatory diseases that occur with excessive immune response against various antigens or environmental factors in sensitive individuals. Atrial electro-mechanic delay (EMD) was suggested as an early marker of atrial fibrillation in previous studies. The objectives of this study were to evaluate atrial electromechanical properties measured by tissue doppler imaging and simultaneous electrocardiography (ECG) tracing in patients with inflammatory bowel disease.

Materials and methods: Thirty-five patients with inflammatory bowel disease (IBD), and 21 healthy volunteers, matched for age and sex, were enrolled in the study. Atrial electromechanical properties were measured by using transthoracic echocardiography and surface ECG. P wave dispersion (PWD), interatrial electro-mechanic delay (EMD), left intraatrial EMD, right intraatrial EMD were calculated.

Results: A total of 35 patients with IBD (54% males; 19 with ulcerative colitis, 16 with Crohn's disease, mean age 43.97 ± 13.98 years) were included in the study. In the patient group, PWD was longer and the P min time was shorter as compared to the control group. Both interatrial (lateral-tricuspid-PA) and left intraatrial (lateral-septal-PA) EMD times were longer in the patient group.

Conclusion: In patients with IBD, PWD, interatrial EMD and left intraatrial EMD were prolonged as compared to the control group. As IBD patients have predisposition to atrial arrhythmic events, those parameters may be used to predict high-risk individuals.

Keywords: Atrial fibrillation, Electromechanical delay, Inflammatory bowel disease, P-wave dispersion

Accepted: December 8, 2018; Published: October 20, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kafes H, Açar B, Asarcikli L, Gucuk E, Yalin Kilic ZM, Tufekcioglu O. P-wave dispersion and atrial electromechanical delay in patients with inflammatory bowel disease. Cor Vasa. 2019;61(5):459-463. doi: 10.33678/cor.2019.035.
Download citation

References

  1. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001;96:1116-1122. Go to original source... Go to PubMed...
  2. Williams H, Walker D, Orchard TR. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep 2008;10:597-605. Go to original source... Go to PubMed...
  3. Danese S, Papa A, Saibeni S, et al. Inflammation and coagulation in inflammatory bowel disease: The clot thickens. Am J Gastroenterol 2007;102:174-186. Go to original source... Go to PubMed...
  4. Bansal D, Chahoud G, Ison K, et al. Pleuropericarditis and pericardial tamponade associated with inflammatory bowel disease. J Ark Med Soc 2005;102:16-19. Go to PubMed...
  5. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375. Go to original source... Go to PubMed...
  6. Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 2001;86:516-521. Go to original source... Go to PubMed...
  7. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002;113:359-364. Go to original source... Go to PubMed...
  8. Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J 2007;28:2803-2817. Go to original source... Go to PubMed...
  9. Hadi HA, Alsheikh-Ali AA, Mahmeed WA, Suwaidi JM. Inflammatory cytokines and atrial fibrillation: current and prospective views. J Inflamm Res 2010;3:75-97. Go to original source... Go to PubMed...
  10. Daubert JC, Pavin D, Jauvert G, Mabo P. Intra- and interatrial conduction delay: implications for cardiac pacing. PACE 2004;27:507-525. Go to original source... Go to PubMed...
  11. Evranos B, Aytemir K, Oto A, et al. Predictors of atrial fibrillation recurrence after atrial fibrillation ablation with cryoballoon. Cardiol J 2013;20:294-303. Go to original source... Go to PubMed...
  12. Efe TH, Cimen T, Ertem AG, et al. Atrial Electromechanical Properties in Inflammatory Bowel Disease. Echocardiography 2016;33:1309-1316. Go to original source... Go to PubMed...
  13. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-3010. Go to original source... Go to PubMed...
  14. Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004;99:97-101. Go to original source... Go to PubMed...
  15. Novacek G, Weltermann A, Sobala A, et al. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology 2010;139:779-787, 787 e1. Go to original source... Go to PubMed...
  16. Irving PM, Pasi KJ, Rampton DS. Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol 2005;3:617-628. Go to original source... Go to PubMed...
  17. Dilaveris P, Stefanadis C. P-wave dispersion and atrial fibrillation risk: methodological considerations. Am J Cardiol 2011;107:1405. Go to original source... Go to PubMed...
  18. Dogan Y, Soylu A, Eren GA, et al. Evaluation of QT and P wave dispersion and mean platelet volume among inflammatory bowel disease patients. Int J Med Sci 2011;8:540-546. Go to original source... Go to PubMed...
  19. Cui QQ, Zhang W, Wang H, et al. Assessment of atrial electromechanical coupling and influential factors in nonrheumatic paroxysmal atrial fibrillation. Clin Cardiol 2008;31:74-78. Go to original source... Go to PubMed...
  20. Omi W, Nagai H, Takamura M, et al. Doppler tissue analysis of atrial electromechanical coupling in paroxysmal atrial fibrillation. J Am Soc Echocardiogr 2005;18:39-44. Go to original source... Go to PubMed...
  21. Ari H, Ari S, Akkaya M, et al. Predictive value of atrial electromechanical delay for atrial fibrillation recurrence. Cardiol J 2013;20:639-647. Go to original source... Go to PubMed...
  22. Shimizu A, Centurion OA. Electrophysiological properties of the human atrium in atrial fibrillation. Cardiovasc Res 2002;54:302-314. Go to original source... Go to PubMed...
  23. Conen D, Ridker PM, Everett BM, et al. A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J 2010;31:1730-1736. Go to original source... Go to PubMed...
  24. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006;27:136-149. Go to original source... Go to PubMed...
  25. Schnabel RB, Larson MG, Yamamoto JF, et al. Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol 2009;104:92-96. Go to original source... Go to PubMed...
  26. Kirchhof P, Bax J, Blomstrom-Lundquist C, et al. Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'. Europace 2009;11:860-885. Go to original source... Go to PubMed...
  27. Acar G, Akcay A, Sayarlioglu M, et al. Assessment of atrial conduction time in patients with familial Mediterranean fever. PACE 2009;32:308-313. Go to original source... Go to PubMed...
  28. Kristensen SL, Lindhardsen J, Ahlehoff O, et al. Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study. Europace 2014;16:477-484. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.